So far, 2022 has been pretty brutal on the market. Rising interest rates, the invasion of the Ukraine, and COVID-19 caused a bear rampage in the first two months of 2022. But you can always find some winners, even in bad markets. That's particularly true in healthcare, always a strong defensive play.
Here's why we think Inspire Medical Systems (NYSE: INSP) , Vertex Pharmaceuticals (NASDAQ: VRTX) , and AstraZeneca (NASDAQ: AZN) will continue to outperform the market in 2022.
Image source: Getty Images.
For further details see:
Don't Tell These 3 Healthcare Stocks There's a Bear Market